October 23, 2012
Astellas Pharma announced on October 22 that mirabegron (generic name), a treatment for overactive bladder (OAB), was recommended for approval by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on October 19 due...read more